GuidelineJournal of the National Cancer Institute2022
Addressing Complementary and Alternative Medicine Use Among Individuals With Cancer: An Integrative Review and Clinical Practice Guideline.
Guideline in Journal of the National Cancer Institute, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 28 papers, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
28 citing papers in PubMed, 1 synthesis or guideline pooled it.
- Complementary therapies in the control of male lower urinary tract symptoms: A systematic review.Revista latino-americana de enfermagem · 2022Pooled it
- Exploring primary care physician feedback following an integrative oncology consultation.Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer · 2023Trial
- Online cancer forums and complementary and alternative medicine in cancer care: effects of ehealth literacy and psychological distress on use and attitudes.Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer · 2026Article
- Exploring biologically-based complementary and alternative medicine use among Irish cancer survivors: findings from a national survey.The oncologist · 2026Article
- Differences in Self-purchased Complementary and Alternative Medicine Use and Patient-reported Satisfaction between Female-specific and Non-female-specific Cancer Patients.Journal of cancer prevention · 2026Article
- Investigating complementary and alternative medicine in Norwegian hospitals: a cross-sectional study with process evaluation.BMC complementary medicine and therapies · 2026Article
- Systems approach to integrative oncology in breast cancer care: service design, delivery and patient experiences from a UK center.Frontiers in oncology · 2026Article
- Use of complementary therapies is associated with expectations of treatment effectiveness among persons with multiple sclerosis.BMJ neurology open · 2026Article
- Communication between Norwegian Pakistani patients and healthcare providers about traditional and complementary medicine: a qualitative study.International journal of qualitative studies on health and well-being · 2025Article
- Comparing the Attitudes of Healthcare Professionals and Cancer Patients Toward the Integration and Perceived Effectiveness of Complementary and Alternative Medicine.Healthcare (Basel, Switzerland) · 2025Article
- Clinical and economic impact of pharmacist interventions to identify drug-related problems in multidisciplinary cancer care: a prospective trial.The oncologist · 2025Article
- Ethnobotanical survey of medicinal plants used in management of breast cancers in Qatar.Heliyon · 2025Article
- Acceptance Scale for Traditional Chinese Medicine Techniques in Cancer Patients: Development and Validation.Patient preference and adherence · 2025Article
- Bridging the gap: attitudes and practices toward complementary and alternative medicine among oncology patients and healthcare professionals in Croatia.Frontiers in psychology · 2025Article
- Fostering the Conversation About Complementary Medicine: Acceptability and Usefulness of Two Communication-Supporting Tools for Patients with Cancer.Current oncology (Toronto, Ont.) · 2024Article
- Cross-Cultural Patient Counseling and Communication in the Integrative Medicine Setting: Respecting the Patient's Health Belief Model of Care.Current psychiatry reports · 2024Review
- Distinct experiences and care needs of advanced cancer patients with good ECOG performance status: a qualitative phenomenological study.BMC palliative care · 2024Article
- Regional Perspectives on Complementary and Alternative Medicine: Results of a Regional Survey.Complementary medicine research · 2024Article
- Cancer patients' behaviors and attitudes toward natural health products.BMC complementary medicine and therapies · 2023Article
- Use of complementary and alternative medicine by cancer patients in Colombia.BMC complementary medicine and therapies · 2023Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Complementary and alternative medicine (CAM) use is common among individuals with cancer, but many choose not to discuss CAM with health-care providers (HCPs). Moreover, there is variability in the provision of evidence-informed decision making about CAM use. A clinical practice guideline was developed to standardize how oncology HCPs address CAM use as well as to inform how individuals with cancer can be supported in making evidence-informed decisions about CAM. An integrative review of the literature, from inception to December 31, 2018, was conducted in MEDLINE, EMBASE, PsychINFO, CINAHL, and AMED databases. Eligible articles included oncology HCPs' practice related to discussing, assessing, documenting, providing decision support, or offering information about CAM. Two authors independently searched the literature, and selected articles were summarized. Recommendations for clinical practice were formulated from the appraised evidence and clinical experiences of the research team. An expert panel reviewed the guideline for usability and appropriateness and recommendations were finalized. The majority of the 30 studies eligible for inclusion were either observational or qualitative, with only 3 being reviews and 3 being experimental. From the literature, 7 practice recommendations were formulated for oncology HCPs regarding how to address CAM use by individuals with cancer, including communicating, assessing, educating, decision coaching, documenting, active monitoring, and adverse event reporting. It is imperative for safe and comprehensive care that oncology HCPs address CAM use as part of standard practice. This clinical practice guideline offers directions on how to support evidence-informed decision making about CAM among individuals with cancer.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.